Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NSE India Stock Exchange  >  Divi's Laboratories Limited    DIVISLAB   INE361B01024

DIVI'S LABORATORIES LIMITED

(DIVISLAB)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
3565.3(c) 3599.45(c) 3605.7(c) 3604.6(c) 3544.7(c) Last
952 462 834 021 730 498 706 058 720 287 Volume
-2.18% +0.96% +0.17% -0.03% -1.66% Change
More quotes
Financials
Sales 2021 68 835 M 943 M 943 M
Net income 2021 19 359 M 265 M 265 M
Net cash position 2021 2 899 M 39,7 M 39,7 M
P/E ratio 2021 48,8x
Yield 2021 0,61%
Sales 2022 80 744 M 1 106 M 1 106 M
Net income 2022 22 718 M 311 M 311 M
Net cash position 2022 5 077 M 69,6 M 69,6 M
P/E ratio 2022 41,1x
Yield 2022 0,68%
Capitalization 941 B 12 893 M 12 895 M
EV / Sales 2021 13,6x
EV / Sales 2022 11,6x
Nbr of Employees 13 884
Free-Float 47,6%
More Financials
Company
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India. 
More about the company
Notations Surperformance© of Divi's Laboratories Limited
Trading Rating : Investor Rating :
More Ratings
All news about DIVI'S LABORATORIES LIMITED
2020Divi's Laboratories Plans $204 Million Investment in New Facility in Andhra P..
MT
2020Indian Indices Close Higher on Monday; Divi's Laboratories Shares Reach All-T..
MT
2020Sensex, Nifty settle higher on pharma boost
RE
2020DIVI'S LABORATORIES LIMITED : annual earnings release
2020DIVI'S LABORATORIES LIMITED : Annual Report
CO
2020DIVI'S LABORATORIES LIMITED : Ex-dividend day for interim dividend
FA
2019DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2018DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2017DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2016DIVI'S LABORATORIES LTD : Ex-dividend day for interim dividend
FA
2015DIVI'S LABORATORIES LTD : BONUS ISSUE: 1 new share for 1 existing share
FA
2015DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2014DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2013DIVI'S LABORATORIES LTD : Press Release Qtr 1 2013-14
PU
2013DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
More news
News in other languages on DIVI'S LABORATORIES LIMITED
2020DIVI'S LABORATORIES LIMITED : Veröffentlichung des Jahresergebnisses
2020DIVI'S LABORATORIES LIMITED : publication des résultats annuels
More news
Chart DIVI'S LABORATORIES LIMITED
Duration : Period :
Divi's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DIVI'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 3 790,24 INR
Last Close Price 3 544,70 INR
Spread / Highest target 27,0%
Spread / Average Target 6,93%
Spread / Lowest Target -23,8%
EPS Revisions
Managers and Directors
NameTitle
Kiran Satchandra Divi Chief Executive Officer & Executive Director
Ramesh B. V. Nimmagadda Non-Executive Chairman
L. Kishore Babu Chief Financial Officer
L. Ramesh Babu Chief Information Officer & VP-Procurement
Ramesh Babu M. General Manager-Technical Operations
Sector and Competitors